FDA Wants Feedback on Sterilizing Device Shipping Forms – Yawn?
Published Date: 7/2/2025
Notice
Summary
The FDA wants your thoughts on a new form that helps track medical devices shipped for sterilization or extra work. This affects companies sending devices to be cleaned or repackaged, and the agency is asking for comments within 60 days. No big costs or changes yet—just making sure the paperwork is clear and easy to handle!
Analyzed Economic Effects
1 provisions identified: 1 benefits, 0 costs, 0 mixed.
New Shipment Form for Sterilization
The FDA is asking for public comment on a proposed form to track nonsterile medical devices that are shipped to other establishments for sterilization, processing, labeling, or repacking. The agency is accepting comments for 60 days under the Paperwork Reduction Act of 1995. This change affects companies that send devices to be cleaned or repackaged.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-16296, Substances Generally Recognized as Safe
The Food and Drug Administration (FDA or we) is proposing to require the submission of generally recognized as safe (GRAS) notices for the use of a human or animal food substance purported to be GRAS under the conditions of its intended use under the Federal Food, Drug, and Cosmetic Act (FD&C Act).
2026-14073, Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign Establishments
The FDA wants to make it easier for drug makers who work in several locations to register as one company instead of many. They’re also updating rules for foreign drug companies to match new laws about handling health threats. If you’re in drug manufacturing, get ready to comment by September 11, 2026, and keep an eye on possible paperwork changes that could affect your business.
2026-13047, Establishment Registration and Product Listing for Tobacco Products
The FDA wants to make sure all tobacco product makers, both in the U.S. and abroad, register their businesses and list their products. This new rule closes a big gap by including foreign companies, helping the FDA keep better track of tobacco products for public health. Comments on this proposal are open until September 14, 2026, so affected businesses should get ready to update their info and possibly face new costs.
2026-16939, GNT USA, LLC.; Filing of Color Additive Petition
The Food and Drug Administration (FDA or we) is announcing that we have filed a petition, submitted by GNT USA, LLC., c/o Exponent, Inc., proposing that we amend our color additive regulations to provide for the safe use of safflower (Carthamus tinctorius L.) extract as a color additive in various foods at levels consistent with good manufacturing practices.
2026-16942, Food Additives Permitted in Feed and Drinking Water of Animals; Chromium DL-methionine Chelate
The Food and Drug Administration (FDA, we, or the Agency) is amending the regulations for food additives permitted in feed and drinking water of animals to provide for the safe use of chromium DL- methionine chelate as a nutritional source of chromium in cattle feed. This action is in response to a food additive petition filed by Zinpro Corp.
2026-16944, Gardenia Blue Interest Group; Filing of Color Additive Petition
The Food and Drug Administration (FDA or we) is announcing that we have filed a petition, submitted by Gardenia Blue Interest Group (GBIG or petitioner), c/o Exponent, Inc., proposing that we amend our color additive regulations to expand the safe use of gardenia (genipin) blue in various foods at levels consistent with good manufacturing practice. The petition also proposes to lower the specification for arsenic in gardenia (genipin) blue.
Previous / Next Documents
Previous: 2025-12304, Self-Regulatory Organizations; NYSE Arca, Inc.; Notice of Filing of Amendment No. 1 to Proposed Rule Change To Amend NYSE Arca Rule 8.500-E and To List and Trade Shares of the Grayscale Digital Large Cap Fund LLC
NYSE Arca wants to update its rules to let people buy and sell shares of the Grayscale Digital Large Cap Fund LLC, a fund focused on digital assets like cryptocurrencies. This change affects investors interested in digital and commodity-based funds and could open new ways to invest starting soon. The SEC is reviewing the proposal, and if approved, trading could begin later in 2025, potentially impacting how digital assets are traded on the exchange.
Next: 2025-12307, Agency Information Collection Activities; Proposed Collection; Comment Request; Environmental Impact Considerations
The FDA wants your thoughts on how it collects info about environmental impacts. This is a chance for anyone affected—like businesses and the public—to share feedback before the agency updates its forms. You’ve got 60 days to weigh in, and no new costs are expected right now.